Illinois quick hits: Stallantis to invest in four states; DHS: Bounties put on ICE
Stallantis to invest in four states
Stellantis has announced plans to expand its U.S. production by 50% with investments in Illinois, Ohio, Michigan and Indiana.
The automaker said it would invest $613 million and create around 3,300 jobs at the Belvidere plant to expand production of the Jeep Cherokee and Jeep Compass for the U.S. market.
Stellantis CEO Antonio Filosa said success in America is good for Stellantis in the U.S. and makes the company stronger everywhere.
DHS: Bounties put on ICE
The U.S. Department of Homeland Security says it has obtained credible intelligence indicating that Mexican criminals have coordinated with domestic extremist groups and placed targeted bounties of up to $50,000 on U.S. Immigration and Customs Enforcement and U.S. Customs and Border Protection personnel.
DHS said in a statement that criminal networks have instructed Chicago street gangs and other “sympathetics” to monitor, harass and assassinate federal agents.
Fence in Broadview down
Workers have taken down a fence outside the U.S. Immigration and Customs Enforcement facility in Broadview.
A federal judge had imposed a deadline of midnight Tuesday night for the fence to be removed, after the village of Broadview filed a motion saying the barrier blocked emergency access.
Latest News Stories
Feds push back on Minnesota prosecution of ICE agent
Minnesota mobile voting push stalls as session ends
Taxpayers fund factories Pentagon says contractors should build
Renewed call for Trump to pardon Texas Republican political consultant
Op-Ed: Illinois is closed for business
Illinois Quick Hits: Proposal would allow two-year, online car registration
Flint, Detroit top list of most-affordable U.S. cities for homebuyers
SCOTUS turns away Palatine HS teacher fired over anti-BLM Facebook posts
WATCH: Critics say political protests interfere with education
Congressional candidates discuss agriculture, healthcare
Trump admin still releasing minors into U.S., well below Biden era
TrumpRx expanding, offering generic prescription drugs